COPPER QUEEN COMM. HOSP. — History
CCN 031312 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$64M
Latest Revenue (FY2022)
+11.9%
Revenue CAGR (3yr)
6.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $51M | $58M | $64M | +10.2% | +11.9% |
| Operating Expenses | $45M | $54M | $59M | +10.5% | +14.6% |
| Operating Margin | 10.9% | 6.9% | 6.6% | -3.8% | -22.2% |
| Net Income | $6M | $4M | $4M | +6.0% | -12.9% |
| Licensed Beds | 14 | 14 | 14 | +0.0% | +0.0% |
| Total Patient Days | 2,409 | 1,897 | 1,765 | -7.0% | -14.4% |
| Medicare Day % | 32% | 29% | 25% | -12.9% | -10.9% |
| Medicaid Day % | 13% | 16% | 9% | -45.0% | -17.7% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +25.3% ($51M → $64M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.9%
This Hospital
+7.6%
State Avg
Latest Margin
6.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $70M | 4.5% |
| FY2024 (proj) | $76M | 2.3% |
| FY2025 (proj) | $83M | 0.1% |